ASPE
Aspen Neuroscience, Inc. Common Stock
Price Chart
Latest Quote
$14.89
-0.11 (-0.73%)
Current Price
| Previous Close | $15.00 |
| Open | $14.70 |
| Day High | $14.89 |
| Day Low | $11.60 |
| Volume | 1,321,063 |
Stock Information
| Shares Outstanding | 29.08M |
| Total Debt | $9.77M |
| Cash Equivalents | $72.38M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $432.98M |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $741.46M |
| Book/sh | $-22.90 |
| Cash/sh | $2.49 |
| Employees | 120 |
Financial Ratios
| Debt/Eq | 11.14 |
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
| P/B | -0.65 |
Analyst Data
| Recommendation | none |
Technical Indicators
Performance History
| YTD | +0.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-30 | $14.89 | 1,322,500 |
About Aspen Neuroscience, Inc. Common Stock
Aspen Neuroscience, Inc. develops autologous induced pluripotent stem cell (iPSC)-derived cell replacement therapies for neurodegenerative diseases. The company's develops ANPD001, an investigational single-dose, autologous dopaminergic neuronal precursor cell (DANPC) therapy for Parkinson's disease. It operates in the United States. The company also advances additional cell replacement candidates targeting both sporadic and genetic forms of Parkinson's disease, as well as other candidates for conditions of the central nervous system (CNS). Aspen Neuroscience, Inc. was formerly known as Aspen Biosciences, Inc. and changed its name to Aspen Neuroscience, Inc. in October 2018. Aspen Neuroscience, Inc. was incorporated in 2018 and is based in San Diego, California.
đ° Latest News
No news articles available at the moment. Check back later for updates on ASPE.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenue | ||
| Total Revenue | $0 | $0 |
| Operating Revenue | $0 | $0 |
| Expenses | ||
| Total Expenses | $59,305,000 | $53,458,000 |
| Other Income Expense | $-4,544,000 | $504,000 |
| Other Non Operating Income Expenses | $-4,544,000 | $504,000 |
| Net Non Operating Interest Income Expense | $1,793,000 | $4,397,000 |
| Operating Expense | $59,305,000 | $53,458,000 |
| General And Administrative Expense | $17,073,000 | $17,383,000 |
| Income & Earnings | ||
| Net Income From Continuing Operation Net Minority Interest | $-62,056,000 | $-48,557,000 |
| Net Interest Income | $1,793,000 | $4,397,000 |
| Interest Income | $1,793,000 | $4,397,000 |
| Normalized Income | $-62,056,000 | $-48,557,000 |
| Net Income From Continuing And Discontinued Operation | $-62,056,000 | $-48,557,000 |
| Total Operating Income As Reported | $-59,305,000 | $-53,458,000 |
| Net Income Common Stockholders | $-62,056,000 | $-48,557,000 |
| Net Income | $-62,056,000 | $-48,557,000 |
| Net Income Including Noncontrolling Interests | $-62,056,000 | $-48,557,000 |
| Net Income Continuous Operations | $-62,056,000 | $-48,557,000 |
| Pretax Income | $-62,056,000 | $-48,557,000 |
| Interest Income Non Operating | $1,793,000 | $4,397,000 |
| Operating Income | $-59,305,000 | $-53,458,000 |
| Depreciation Amortization Depletion Income Statement | $399,000 | $482,000 |
| Depreciation And Amortization In Income Statement | $399,000 | $482,000 |
| Depreciation Income Statement | $399,000 | $482,000 |
| Per Share | ||
| Diluted EPS | $-0.47 | $-0.25 |
| Basic EPS | $-0.47 | $-0.25 |
| Other | ||
| Tax Effect Of Unusual Items | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-55,347,000 | $-49,945,000 |
| Reconciled Depreciation | $3,958,000 | $3,513,000 |
| EBITDA (Bullshit earnings) | $-55,347,000 | $-49,945,000 |
| EBIT | $-59,305,000 | $-53,458,000 |
| Diluted Average Shares | $136,117,025 | $194,563,914 |
| Basic Average Shares | $136,117,025 | $194,563,914 |
| Diluted NI Availto Com Stockholders | $-62,056,000 | $-48,557,000 |
| Research And Development | $41,833,000 | $35,593,000 |
| Selling General And Administration | $17,073,000 | $17,383,000 |
| Other Gand A | $7,280,000 | $7,153,000 |
| Salaries And Wages | $9,793,000 | $10,230,000 |
Fetched: 2026-10-31
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Assets | ||
| Net Tangible Assets | $-217,077,000 | $-157,727,000 |
| Total Assets | $143,663,000 | $90,211,000 |
| Total Non Current Assets | $31,277,000 | $30,621,000 |
| Other Non Current Assets | $622,000 | $622,000 |
| Non Current Deferred Assets | $58,000 | $513,000 |
| Non Current Note Receivables | $944,000 | $5,496,000 |
| Current Assets | $112,386,000 | $59,590,000 |
| Other Current Assets | $1,687,000 | $1,908,000 |
| Cash Cash Equivalents And Short Term Investments | $110,699,000 | $57,682,000 |
| Cash And Cash Equivalents | $82,097,000 | $15,221,000 |
| Cash Equivalents | $81,590,000 | $7,386,000 |
| Cash Financial | $507,000 | $7,835,000 |
| Debt | ||
| Total Debt | $11,201,000 | $13,829,000 |
| Long Term Debt And Capital Lease Obligation | $7,669,000 | $10,400,000 |
| Current Debt And Capital Lease Obligation | $3,532,000 | $3,429,000 |
| Liabilities | ||
| Total Liabilities Net Minority Interest | $360,740,000 | $247,938,000 |
| Total Non Current Liabilities Net Minority Interest | $346,477,000 | $233,900,000 |
| Current Liabilities | $14,263,000 | $14,038,000 |
| Other Current Liabilities | $109,000 | $151,000 |
| Current Deferred Liabilities | $377,000 | $1,479,000 |
| Payables And Accrued Expenses | $4,593,000 | $3,364,000 |
| Payables | $2,640,000 | $853,000 |
| Accounts Payable | $2,640,000 | $853,000 |
| Other Non Current Liabilities | - | $20,000 |
| Equity | ||
| Common Stock Equity | $-217,077,000 | $-157,727,000 |
| Total Equity Gross Minority Interest | $-217,077,000 | $-157,727,000 |
| Stockholders Equity | $-217,077,000 | $-157,727,000 |
| Gains Losses Not Affecting Retained Earnings | $13,000 | $39,000 |
| Other Equity Adjustments | $13,000 | $39,000 |
| Retained Earnings | $-228,340,000 | $-166,284,000 |
| Preferred Securities Outside Stock Equity | $338,808,000 | $223,480,000 |
| Other | ||
| Ordinary Shares Number | $29,078,600 | $29,078,600 |
| Share Issued | $29,078,600 | $29,078,600 |
| Tangible Book Value | $-217,077,000 | $-157,727,000 |
| Invested Capital | $-217,077,000 | $-157,727,000 |
| Working Capital | $98,123,000 | $45,552,000 |
| Capital Lease Obligations | $11,201,000 | $13,829,000 |
| Total Capitalization | $-217,077,000 | $-157,727,000 |
| Additional Paid In Capital | $11,249,000 | $8,517,000 |
| Capital Stock | $1,000 | $1,000 |
| Common Stock | $1,000 | $1,000 |
| Long Term Capital Lease Obligation | $7,669,000 | $10,400,000 |
| Current Capital Lease Obligation | $3,532,000 | $3,429,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $5,652,000 | $5,615,000 |
| Current Accrued Expenses | $1,953,000 | $2,511,000 |
| Net PPE | $29,653,000 | $23,990,000 |
| Accumulated Depreciation | $-4,536,000 | $-2,899,000 |
| Gross PPE | $34,189,000 | $26,889,000 |
| Leases | $5,653,000 | $5,653,000 |
| Construction In Progress | $10,866,000 | $2,789,000 |
| Other Properties | $16,271,000 | $17,152,000 |
| Machinery Furniture Equipment | $1,399,000 | $1,295,000 |
| Properties | $0 | $0 |
| Other Short Term Investments | $28,602,000 | $42,461,000 |
Fetched: 2026-10-31
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Free Cash Flow | ||
| Free Cash Flow | $-62,537,000 | $-46,746,000 |
| Operating Activities | ||
| Operating Cash Flow | $-52,847,000 | $-44,162,000 |
| Cash Flow From Continuing Operating Activities | $-52,847,000 | $-44,162,000 |
| Investing Activities | ||
| Capital Expenditure | $-9,690,000 | $-2,584,000 |
| Investing Cash Flow | $4,197,000 | $20,631,000 |
| Cash Flow From Continuing Investing Activities | $4,197,000 | $20,631,000 |
| Financing Activities | ||
| Issuance Of Capital Stock | $115,353,000 | $0 |
| Financing Cash Flow | $115,526,000 | $457,000 |
| Cash Flow From Continuing Financing Activities | $115,526,000 | $457,000 |
| Net Preferred Stock Issuance | $115,353,000 | $0 |
| Preferred Stock Issuance | $115,353,000 | $0 |
| Net Other Financing Charges | - | $-10,000 |
| Other | ||
| End Cash Position | $82,719,000 | $15,843,000 |
| Beginning Cash Position | $15,843,000 | $38,917,000 |
| Changes In Cash | $66,876,000 | $-23,074,000 |
| Proceeds From Stock Option Exercised | $173,000 | $467,000 |
| Net Investment Purchase And Sale | $13,887,000 | $23,215,000 |
| Sale Of Investment | $47,500,000 | $103,101,000 |
| Purchase Of Investment | $-33,613,000 | $-79,886,000 |
| Net PPE Purchase And Sale | $-9,690,000 | $-2,584,000 |
| Purchase Of PPE | $-9,690,000 | $-2,584,000 |
| Change In Working Capital | $-1,765,000 | $631,000 |
| Change In Other Current Liabilities | $-2,732,000 | $-2,403,000 |
| Change In Other Current Assets | $454,000 | $-299,000 |
| Change In Payables And Accrued Expense | $293,000 | $3,475,000 |
| Change In Accrued Expense | $-1,495,000 | $3,779,000 |
| Change In Payable | $1,788,000 | $-304,000 |
| Change In Account Payable | $1,788,000 | $-304,000 |
| Change In Prepaid Assets | $220,000 | $-142,000 |
| Other Non Cash Items | $-53,000 | $-1,960,000 |
| Stock Based Compensation | $2,517,000 | $2,707,000 |
| Unrealized Gain Loss On Investment Securities | $4,552,000 | $-496,000 |
| Amortization Of Securities | $-53,000 | $-1,960,000 |
| Depreciation Amortization Depletion | $3,958,000 | $3,513,000 |
| Depreciation And Amortization | $3,958,000 | $3,513,000 |
| Depreciation | $3,958,000 | $3,513,000 |
| Net Income From Continuing Operations | $-62,056,000 | $-48,557,000 |
Fetched: 2026-10-31